FR2791675B1 - Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique - Google Patents

Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique

Info

Publication number
FR2791675B1
FR2791675B1 FR9903936A FR9903936A FR2791675B1 FR 2791675 B1 FR2791675 B1 FR 2791675B1 FR 9903936 A FR9903936 A FR 9903936A FR 9903936 A FR9903936 A FR 9903936A FR 2791675 B1 FR2791675 B1 FR 2791675B1
Authority
FR
France
Prior art keywords
benzodioxinne
methanamine
aminophenyl
dihydro
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9903936A
Other languages
English (en)
Other versions
FR2791675A1 (fr
Inventor
Yannick Evanno
Peretti Daniele De
Jean Francois Gibert
Michel Charles Peynot
Jocelyne Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to FR9903936A priority Critical patent/FR2791675B1/fr
Priority to PCT/FR2000/000762 priority patent/WO2000058301A1/fr
Priority to AU36607/00A priority patent/AU3660700A/en
Priority to CO00022433A priority patent/CO5170535A1/es
Priority to UY26085A priority patent/UY26085A1/es
Priority to PE2000000275A priority patent/PE20001598A1/es
Publication of FR2791675A1 publication Critical patent/FR2791675A1/fr
Application granted granted Critical
Publication of FR2791675B1 publication Critical patent/FR2791675B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
FR9903936A 1999-03-30 1999-03-30 Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique Expired - Fee Related FR2791675B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR9903936A FR2791675B1 (fr) 1999-03-30 1999-03-30 Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
PCT/FR2000/000762 WO2000058301A1 (fr) 1999-03-30 2000-03-27 Derives de n-[2-(4-aminophenyl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-methanamine, leur preparation et leur application en therapeutique
AU36607/00A AU3660700A (en) 1999-03-30 2000-03-27 N-(2-(4-aminophyl)ethyl)-2,3-dihydro-1,4-benzodioxine-2-met hanamine, production and therapeutic use thereof
CO00022433A CO5170535A1 (es) 1999-03-30 2000-03-29 Derivados de n-[2-(4-aminofenil)etil]2,3-dihidro-1,4- benzodioxin-2-metanamina, su preparacion y su aplciacion en terapeutica
UY26085A UY26085A1 (es) 1999-03-30 2000-03-29 N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
PE2000000275A PE20001598A1 (es) 1999-03-30 2000-03-30 Derivados de n-[2-(4-aminofenil)etil]-2,3-dihidro-1,4-benzodioxin-2-metanamina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9903936A FR2791675B1 (fr) 1999-03-30 1999-03-30 Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2791675A1 FR2791675A1 (fr) 2000-10-06
FR2791675B1 true FR2791675B1 (fr) 2001-05-04

Family

ID=9543788

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9903936A Expired - Fee Related FR2791675B1 (fr) 1999-03-30 1999-03-30 Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique

Country Status (6)

Country Link
AU (1) AU3660700A (fr)
CO (1) CO5170535A1 (fr)
FR (1) FR2791675B1 (fr)
PE (1) PE20001598A1 (fr)
UY (1) UY26085A1 (fr)
WO (1) WO2000058301A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
GT200600078A (es) 2005-02-17 2007-04-12 Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquil condensados
US7365095B2 (en) 2005-04-22 2008-04-29 Wyeth Chromane and chromene derivatives and uses thereof
PE20061335A1 (es) * 2005-04-22 2006-12-29 Wyeth Corp Compuestos derivados de benzodioxano y benzodioxolano como moduladores del receptor 5-ht2c
AR060493A1 (es) * 2006-04-18 2008-06-18 Wyeth Corp Derivados de benzodioxano y benzodioxolano. procesos de obtencion.
AR063373A1 (es) * 2006-10-24 2009-01-21 Wyeth Corp Derivados de benzodioxano y sus usos
EP2271638B1 (fr) 2008-04-29 2011-08-31 NSAB, Filial af NeuroSearch Sweden AB, Sverige Modulateurs de la neurotransmission de la dopamine
US20110105462A1 (en) * 2008-04-29 2011-05-05 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Modulators of dopamine neurotransmission
CN102036976B (zh) 2008-04-29 2013-05-01 Nsab神经研究瑞典公司分公司 多巴胺神经传递的调节剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281245A (fr) * 1962-07-20
CA1147342A (fr) * 1977-10-12 1983-05-31 Kazuo Imai Procede de preparation de nouveaux derives de la phenylethanolamine

Also Published As

Publication number Publication date
FR2791675A1 (fr) 2000-10-06
AU3660700A (en) 2000-10-16
WO2000058301A1 (fr) 2000-10-05
UY26085A1 (es) 2000-10-31
PE20001598A1 (es) 2001-04-01
CO5170535A1 (es) 2002-06-27

Similar Documents

Publication Publication Date Title
MA27049A1 (fr) Derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2-one, leur preparation et leur application en therapeutique
FR2790474B1 (fr) Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
FR2832713B1 (fr) Derives de 4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
FR2843964B1 (fr) Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
MA27233A1 (fr) Derives de piperazinylacylpiperidine, leur preparation et leur application en therapeutique
FR2786482B1 (fr) Nouveaux derives de 2-pyridone, leur preparation et leur application en therapeutique
FR2850377B1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
FR2791675B1 (fr) Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
FR2880023B1 (fr) Derives de n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine leur preparation et leur application en therapeutique
FR2761071B1 (fr) Derives de quinolein-2(1h)-one et de dihydroquinolein-2(1h)- one, leur preparation et leur application en therapeutique
FR2792318B1 (fr) Derives d'indazole, leur preparation et leur application en therapeutique
FR2788776B1 (fr) Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2753970B1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
FR2862967B1 (fr) Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique
FR2806722B1 (fr) Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
BR9911178B1 (pt) Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenometil)-cefems, bem como preparação farmacêutica e uso dos mesmos
FR2842527B1 (fr) Derives d'acyloxypyrolidine, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2792635B1 (fr) Derives de cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2790472B1 (fr) Derives de cyclobutene-3, 4-dione, leur preparation et leur application en therapeutique
FR2765581B1 (fr) Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
FR2792634B1 (fr) Derives de 2-alcoxy-cyclobutene-3,4-dione leur preparation et leur application en therapeutique
FR2741071B1 (fr) Derives de 3-(benzofuran-5-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2750427B1 (fr) Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
CD Change of name or company name
PLFP Fee payment

Year of fee payment: 17

ST Notification of lapse

Effective date: 20161130